NCT01019772View on ClinicalTrials.gov

Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age

PHASE3CompletedINTERVENTIONAL

Enrollment

217

Participants

Timeline

Start Date

July 31, 2007

Study Completion Date

August 31, 2008

Conditions

Infectious Disease by Haemophilus Influenzae Type b

Interventions

BIOLOGICAL

LBVH0101 (Hib vaccine)

BIOLOGICAL

Hiberix™ Vaccine

Trial Locations (1)

110-769

Seoul National University Children's Hospital, Seoul

Sponsors

Lead Sponsor

LG Life Sciences

All Listed Sponsors

lead

LG Life Sciences

INDUSTRY

NCT01019772 - Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age | Biotech Hunter | Biotech Hunter